Tenaya Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Tenaya Therapeutics Operating Expenses Growth & History (TNYA)
Tenaya Therapeutics's operating expenses was $93.3M for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $93.3M | −$22.6M | −19.51% |
| 2024 | 2024-12-31 | $115.9M | −$15.2M | −11.62% |
| 2023 | 2023-12-31 | $131.2M | $5.6M | +4.44% |
| 2022 | 2022-12-31 | $125.6M | $52.8M | +72.54% |
| 2021 | 2021-12-31 | $72.8M | $33.9M | +87.10% |
| 2020 | 2020-12-31 | $38.9M | — | — |
Tenaya Therapeutics quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $45.2M | $21.1M | +87.68% |
| Q1 2026 | 2026-03-31 | $20.3M | −$7.2M | −26.32% |
| Q4 2025 | 2025-12-31 | $20.8M | −$3.9M | −15.73% |
| Q3 2025 | 2025-09-30 | $20.9M | −$5.8M | −21.62% |
| Q2 2025 | 2025-06-30 | $24.1M | −$6.7M | −21.87% |
| Q1 2025 | 2025-03-31 | $27.5M | −$6.2M | −18.43% |
| Q4 2024 | 2024-12-31 | $24.7M | −$6.8M | −21.61% |
| Q3 2024 | 2024-09-30 | $26.7M | −$4.2M | −13.61% |
| Q2 2024 | 2024-06-30 | $30.8M | −$4.3M | −12.20% |
| Q1 2024 | 2024-03-31 | $33.8M | $39,000 | +0.12% |
| Q4 2023 | 2023-12-31 | $31.4M | −$3.1M | −8.98% |
| Q3 2023 | 2023-09-30 | $30.9M | −$378,000 | −1.21% |
| Q2 2023 | 2023-06-30 | $35.1M | $6.5M | +22.66% |
| Q1 2023 | 2023-03-31 | $33.7M | $2.6M | +8.25% |
| Q4 2022 | 2022-12-31 | $34.5M | $8.4M | +32.05% |
| Q3 2022 | 2022-09-30 | $31.3M | $13.0M | +71.03% |
| Q2 2022 | 2022-06-30 | $28.6M | $13.4M | +87.83% |
| Q1 2022 | 2022-03-31 | $31.2M | $18.0M | +137.73% |
| Q4 2021 | 2021-12-31 | $26.2M | — | — |
| Q3 2021 | 2021-09-30 | $18.3M | $7.8M | +75.09% |
| Q2 2021 | 2021-06-30 | $15.2M | $6.4M | +71.74% |
| Q1 2021 | 2021-03-31 | $13.1M | — | — |
| Q3 2020 | 2020-09-30 | $10.5M | — | — |
| Q2 2020 | 2020-06-30 | $8.9M | — | — |
Tenaya Therapeutics operating expenses trends
Over the last five fiscal years, Tenaya Therapeutics's operating expenses increased from $38.9M to $93.3M, a change of $54.4M. The latest reported quarter, Q2 2026, shows $45.2M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗